Role of down-regulated expression of vitamin D receptor mediated by fibroblast growth factor 23 and bone morphogenetic protein 7 in rats with type 2 diabetes and osteoporosis

( views:426, downloads:0 )
Author:
LI Bao-xin(The Second Section Department of Endocrinology, The Third Hospital, Hebei Medical University, Shijiazhuang, 050051, China)
WANG Yan(The Second Section Department of Endocrinology, The Third Hospital, Hebei Medical University, Shijiazhuang, 050051, China)
LIU Yan(The Second Section Department of Endocrinology, The Third Hospital, Hebei Medical University, Shijiazhuang, 050051, China)
MA Jian-xia(The Second Section Department of Endocrinology, The Third Hospital, Hebei Medical University, Shijiazhuang, 050051, China)
LI Yu-kun(The Second Section Department of Endocrinology, The Third Hospital, Hebei Medical University, Shijiazhuang, 050051, China)
Journal Title:
Chinese Journal of Biomedical Engineering
Issue:
Volume 18, Issue 03, 2012
DOI:
10.3760/cma.j.issn.1674-1927.2012.03.008
Key Word:
Diabetes mellitus,type 2;Osteoporosis;Receptors,calcitriol;Fibroblast growth factor 23;Bone morphogenetic protein 7

Abstract: Objective To investigate the expression and significance of Vitamin D receptor (VDR),fibroblast growth factor(FGF) 23 and bone morphogenetic protein(BMP) 7 in the kidney and bone tissues in rats with type 2 diabetes and osteoporosis.Methods Female Wistar rats were randomly divided into four groups:sham control group (NS group),ovariectomy group (NOVX group),type 2 diabetes sham surgery group (DS group) and type 2 diabetic rats undergoing ovariectomy group (DOVX group).In diabetes groups,rats were administrated with high-sugar-fat diet and intraperitoneal injection of small dose of streptozotocin so as to establish type 2 diabetes models (T2DMs).After the models were successfully established,the ovariectomy groups received ovariectomy and were randomly sacrificed at the end of week 4,8 and 12 after ovariectomy in batches.The mRNA expression levels of VDR,FGF23 and BMP7 in kidney and bone tissues in each group were observed by RT-PCR and the protein expression levels of VDR,FGF23 and BMP7 in kidney tissues by Western blot.Results The models of type 2 diabetes with osteoporosis were successfully established.Both mRNA expression levcls of VDR and BMP7 in kidney and bone tissues and the protein expression levels of VDR and BMP7 in kidney tissues of DS and DOVX groups were lower than those of NS and NOVX groups along with time (P<0.05).DS and DOVX groups had significantly lower mRNA expression of FGF23 in bone tissues as compared with NS and NOVX groups(0.566±0.059,0.452±0.057 vs 1.008±0.068,0.520±0.049,P<0.05),but the mRNA and protein expression of FGF23 in kidney tissues of DS and DOVX groups was significantly higher than that of NS and NOVX groups (protein:1.034±0.071,1.136±0.112 vs 0.919±0.086,0.952±0.143),with expression level in DOVX group being the highest(P< 0.05).Conclusion The expression of vitamin D receptor(VDR) mediated by both FGF23 and BMP7 may not exert effects on rats of type 2 diabetes with osteoporosis.

  • [1]Bouillon R,Carmeliet G,Verlinden L,et al.Vitamin D and human health:lessons from vitamin D receptor null mice.Endocr Rev,2008,29:726-776.
  • [2]Ti Y,Xie GL,Wang ZH,et al.TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat modcl.Diabetes,2011,60:2963-2974.
  • [3]Ferretti M,Bertoni L,Cavani F,et al.Structural and histomorphometric evaluations of ferutinin effects on the uterus of ovariectomized rats during osteoporosis treatment.Life Sci,2012,90:161-168.
  • [4]Li X,Ominsky MS,Warmington KS,et al.Sclerostin antibody treatment increascs bone formation,bone mass,and bone strength in a rat model of postmenopausal osteoporosis.J Bone Miner Res.2009,24:578-588.
  • [5]王燕,李宝新,刘岩,等.2型糖尿病骨质疏松大鼠骨重建研究基础医学与临床,2011,31:777-782.
  • [6]Bischoff Ferrari HA,Wiltett WC,Wong JB,et al.Prevention of nonvertebral fractures with oral vitamin D and dose dependency:a meta analysis of randomized controlled trials.Arch Intern Med,2009,169:55t-561.
  • [7]Osei K.25-OH vitamin D:is it the universal panacea for metabolic syndrome and type 2 diabetes? J Clin Endocrinol Mctab,2010,95:4220-4222.
  • [8]Scragg R.Vitamin D and type 2 diabetes:are we ready for a preventiontrial? Diabetes,2008,57:2565-2566.
  • [9]Bouillon R,Carmeliet G,Verlinden L,et al.Vitamin D and human hcalth:lessons from vitamin D receptor null mice.Endocr Rev,2008,29:726-776.
  • [10]李宝新,李玉坤.FGFs/FGFRs系统对骨调节的研究进展.中国细胞生物学学报,2011,33:318-321.
  • [11]Shimada T,Urakawa I,Isakova T,et al.Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.J Clin Endocrinol Metab,2010,95:578-585.
  • [12]Razzaque MS,St-Arnaud R,Taguchi T,et al.FGF-23,vitamin D and calcification:the unholy triad.Nephrol Dial Transplant,2005,20:2032-2035.
  • [13]Tang WJ,Wang LF,Xu XY,et al.Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts.Calcif Tissue Int,2010,86:404-410.
  • [14]Prié D,Fricdlander G.Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.Clin J Am Soc Ncphrol,2010,5:1717-1722.
  • [15]Tsuji K,Maeda T,Kawane T,et al.Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses reual lalpha,25-dihydroxyvitamin D3 synthesis in leptin-deficient mice.J Bone Miner Rcs,2010,25:1711-1723.
  • [16]Hu J,Qi MC,Zou SJ,et al.Callus formation enhanced by BMP-7 ex vivo gene therapy during distraction osteogenesis in rats.J Orthop Res,2007,25:2412-2451.
  • [17]Sugimoto H,Grahovac G,Zeisherg M,et al.Renal fihrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by hone morphogenic protein-7 and advanced glycation end product inhibitors.Diabetes,2007,56:1825-1833.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn